Clinical Trial Update: Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA) [NA]

View source ↗

Summary

The PETRA trial, investigating positron emission tomography in rheumatoid arthritis patients treated with adalimumab, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: University Hospital, Tours | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED